The company designed its FDA 510(k)-pending system to unlock advanced imaging capabilities in cardiology, oncology and other areas. It unveiled Signa Sprint at the International Society for Magnetic Resonance in Medicine (ISMRM) 2025.

GE HealthCare said the system delivers high-performance scanning made simple at 1.5T. It features exceptional diffusion imaging for oncology diagnosis and treatment planning, too. The company says its system equips clinicians and researchers with the ability to expand the current 1.5T boundaries.